Body Weight, Aspirin Dose and Pro-resolving Mediators
NCT04697719
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
103
Enrollment
OTHER
Sponsor class
Conditions
Body Weight
Interventions
DRUG:
Aspirin 81mg
DRUG:
Aspirin 325mg
Sponsor
NYU Langone Health